Literature DB >> 31390524

DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.

Khondakar Sayef Ahammed1, Ritesh Pal1,2, Jeet Chakraborty1, Ajay Kanungo1,2, Polnati Sravani Purnima1, Sanjay Dutta1,2.   

Abstract

Structural integrity of the bacterial genome plays an important role in bacterial survival. Cellular consequences of an intolerable amount of change in the DNA structure are not well understood in bacteria. Here we have stated that binding of synthetic 6-nitroquinoxaline derivatives with DNA led to change in its global structure, subsequently culminating with over-supercoiled form through in-path intermediates. This structural change results in induction of programmed cell death like physiological hallmarks, which is dependent on substitution driven structural modulation properties of the scaffold. A sublethal dose of a representative derivative, 3a, significantly inhibits DNA synthesis, produces fragmented nucleoids, and alters membrane architecture. We have also shown that exposure to the compound changes the native morphology of Staphylococcus aureus cells and significantly disrupts preformed biofilms. Thus, our study gives new insight into bacterial responses to local or global DNA structural changes induced by 6-nitroquinoxaline small molecules.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31390524     DOI: 10.1021/acs.jmedchem.9b00599

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Activities of Quinoxaline, Nitroquinoxaline, and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni.

Authors:  Stefan L Debbert; Mikaela J Hintz; Christian J Bell; Kenya R Earl; Grant E Forsythe; Cécile Häberli; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Cleavage of Abasic Sites in DNA by an Aminoquinoxaline Compound: Augmented Cytotoxicity and DNA Damage in Combination with an Anticancer Drug Chlorambucil in Human Colorectal Carcinoma Cells.

Authors:  Chandra Sova Mandi; Tridib Mahata; Dipendu Patra; Jeet Chakraborty; Achyut Bora; Ritesh Pal; Sanjay Dutta
Journal:  ACS Omega       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.